Primary study · included by 1 review

Mercado 2021

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Use of cells and/or biologics combined with scaffolds in alveolar bone augmentation for implant site development.

Non-Cochrane · intervention · 2026 · cited as Mercado 2021 · Forest plot Figure 3 or 4; Supplement Table 1

Outcome this study informs	Pooled effect	Evidence	Certainty
Mineralized tissue (%) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD 7.46 [-10.94, 25.86]	5 studies	GRADE not reported
Ridge height change (mm) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD 0.40 [0.16, 0.63]	6 studies	GRADE not reported
Ridge width change (mm) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD 0.48 [0.03, 0.93]	7 studies	GRADE not reported
Residual graft (%) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD -5.01 [-12.19, 2.17]	5 studies	GRADE not reported
Non-mineralized tissue (%) Biologics combined with scaffolds vs Scaffold or guided bone regeneration without biologics	WMD -14.87 [-26.05, -3.68]	2 studies	GRADE not reported

1 including review in total.